Home Newsfeeds OneSpan Working With Evercore To Explore A Sale

OneSpan Working With Evercore To Explore A Sale

– Reuters Citing Sources

byHappy Mohamed

March 2, 2023

1 minute read

– Reuters Citing Sources

News

Bionano Genomics Announces Launch Of CLIA-Certified Bionano Laboratories, And Expands Its Clinical Testing Menu With Launch Of First OGM-Based LDT For FSHD

By Benzinga Newsdesk

September 23, 8:03 AM

Bionano Genomics, Inc. (NASDAQ:BNGO) today announced the launch of Bionano Laboratories, a new organization that combines Bionano's optical genome mapping (OGM) data services with the clinical testing services

BNGO

S&P 500 Rebounds From 2022 Lows This Week As Big Tech Earnings Loom Large

By Wayne Duggan

October 21, 3:21 PM

The SPDR S&P 500 ETF Trust (NYSE: SPY) rebounded from its 2022 lows this week as investors digested a mixed bag of corporate earnings reports.

AAPL

Sachem Capital Q2 EPS $0.12 Up From $0.10 YoY, Sales $12.50M Up From $6.71M YoY

By Bill Haddad

August 4, 7:16 PM

Sachem Capital (AMEX:SACH) reported quarterly earnings of $0.12 per share. This is a 20 percent increase over earnings of $0.10 per share from the same period last year. The company reported $12.50 million in sales this

SACH

Griffon Lowers FY23 Revenue Guidance To $2.7B (Prior $2.95B) Vs $2.9B Estimate; Sees Adjusted EBITDA Of At Least $525M (Prior $500M)

By Benzinga Newsdesk

May 3, 8:09 AM

2023 Outlook We now expect 2023 revenue of $2.7 billion (prior $2.95 billion) reflecting decreased CPP revenue, primarily driven by reduced consumer demand and ongoing elevated levels of customer

GFF

OneSpan Working With Evercore To Explore A Sale

Related Posts

Bionano Genomics Announces Launch Of CLIA-Certified Bionano Laboratories, And Expands Its Clinical Testing Menu With Launch Of First OGM-Based LDT For FSHD

S&P 500 Rebounds From 2022 Lows This Week As Big Tech Earnings Loom Large

Sachem Capital Q2 EPS $0.12 Up From $0.10 YoY, Sales $12.50M Up From $6.71M YoY

Griffon Lowers FY23 Revenue Guidance To $2.7B (Prior $2.95B) Vs $2.9B Estimate; Sees Adjusted EBITDA Of At Least $525M (Prior $500M)